# ![@Zellchair Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2011104618085040128.png) @Zellchair Zellchair

Zellchair posts on X about $fbio, $fbiop, in the, to the the most. They currently have [--] followers and [--] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::2011104618085040128/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2011104618085040128/c:line/m:interactions.svg)

- [--] Week [-----] +981%

### Mentions: [--] [#](/creator/twitter::2011104618085040128/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2011104618085040128/c:line/m:posts_active.svg)


### Followers: [--] [#](/creator/twitter::2011104618085040128/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2011104618085040128/c:line/m:followers.svg)

- [--] Week [--] +200%

### CreatorRank: [---------] [#](/creator/twitter::2011104618085040128/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2011104618085040128/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance)  [countries](/list/countries)  [stocks](/list/stocks) 

**Social topic influence**
[$fbio](/topic/$fbio) #1, [$fbiop](/topic/$fbiop) #1, [in the](/topic/in-the), [to the](/topic/to-the), [update](/topic/update), [link](/topic/link), [india](/topic/india), [mexico](/topic/mexico), [brazil](/topic/brazil), [capabilities](/topic/capabilities)

**Top assets mentioned**
[4D Molecular Therapeutics Inc. (FDMT)](/topic/$fdmt)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Fortress Biotech $FBIO $FBIOP All circles that can be closed within Gut seems to be closed within Crystalys now. Former Chairman President & CEO of Horizon Therapeutic which was acquired by Amgen (much because of KRYSTEXXA in Gut) now joins Crytalys. https://www.prnewswire.com/news-releases/crystalys-therapeutics-appoints-tim-walbert-former-horizon-therapeutics-ceo-as-independent-board-director-302684374.html https://www.prnewswire.com/news-releases/crystalys-therapeutics-appoints-tim-walbert-former-horizon-therapeutics-ceo-as-independent-board-director-302684374.html"  
[X Link](https://x.com/anyuser/status/2021602249223323961)  2026-02-11T15:08Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP UNLOXCYT Listen to the experts. Never heard so many "exciting" in such a short time. The fact that the study was done in the majority in the EU and Australia bodes well for the decisions on approval in these markets. https://thedermdigest.com/heres-why-dermatologists-are-excited-about-cosibelimab-ipdl-for-cscc-with-dr-emily-s-ruiz/ https://thedermdigest.com/heres-why-dermatologists-are-excited-about-cosibelimab-ipdl-for-cscc-with-dr-emily-s-ruiz/"  
[X Link](https://x.com/anyuser/status/2022375334050443649)  2026-02-13T18:20Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen to the Q&A around 30:45 and 39:45. https://zyduslife.com/public/pdf/EditedAudio.mp3 https://zyduslife.com/public/pdf/EditedAudio.mp3"  
[X Link](https://x.com/anyuser/status/2021235936281981390)  2026-02-10T14:52Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 2/2 I interpreted it as: [--]. Sentynl will have a strong coming year largely due to ZYCUBO [--]. ZYCUBO will be a driving part of the US business (first answer option from the respondent) in the coming years Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen to the Q&A around 30:45 and 39:45. https://t.co/Lv6Fvhd5H4 Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen"  
[X Link](https://x.com/anyuser/status/2021236280768479584)  2026-02-10T14:54Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Sun Pharma - Marketing - Super Bowl On the branded side of things Suns skin cancer offerings include . Unloxcyt an FDA-approved PD-L1 therapy for advanced cutaneous squamous cell carcinoma ." https://www.fiercepharma.com/marketing/sun-pharma-marks-super-bowl-sunday-skin-cancer-awareness-drive https://www.fiercepharma.com/marketing/sun-pharma-marks-super-bowl-sunday-skin-cancer-awareness-drive"  
[X Link](https://x.com/Zellchair/status/2019730297215176827)  2026-02-06T11:10Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Now the transcript has been released from Sun Pharma's latest quarter report last week. Recommended reading with several interesting details about UNLOXCYT launch. https://sunpharma.com/wp-content/uploads/2026/01/Press-Release-Sun-Pharma-Q3FY26-financial-result-on-January-31-2026.pdf https://sunpharma.com/wp-content/uploads/2026/01/Press-Release-Sun-Pharma-Q3FY26-financial-result-on-January-31-2026.pdf"  
[X Link](https://x.com/Zellchair/status/2020504784919527830)  2026-02-08T14:27Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 1/2 Quote from Zydus' latest earnings call November [--] [----] (link). I expect Zydus/Sentynl to cover large markets where they have good sales capabilities in India USA Mexico and Brazil. https://zyduslife.com/investor/admin/uploads/16/0/Earnings-call-transcript-06-Nov-25.pdf https://zyduslife.com/investor/admin/uploads/16/0/Earnings-call-transcript-06-Nov-25.pdf"  
[X Link](https://x.com/anyuser/status/2020851531524833480)  2026-02-09T13:25Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Fortress Biotech - Helocyte (Part 3) Triplex Universal Multi-Antigen MVA-based CMV Vaccine https://zellchair.substack.com/p/fortress-biotech-helocyte-part-3 https://zellchair.substack.com/p/fortress-biotech-helocyte-part-3"  
[X Link](https://x.com/Zellchair/status/2019504229929320834)  2026-02-05T20:11Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Fortress Biotech - Helocyte (Part 4) Triplex Indications https://zellchair.substack.com/p/fortress-biotech-helocyte-part-4 https://zellchair.substack.com/p/fortress-biotech-helocyte-part-4"  
[X Link](https://x.com/Zellchair/status/2020189926344782166)  2026-02-07T17:36Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Menkes ZYCUBO - China With the advancement of the marketing application it is expected that Zycubo will be officially approved in China in 2027-2028 filling the gap in the specific treatment of Menkes disease in China" http://www.kaicheong.hk/a/xinwenzhongxin/2026020711946.html http://www.kaicheong.hk/a/xinwenzhongxin/2026020711946.html"  
[X Link](https://x.com/anyuser/status/2020193852842295702)  2026-02-07T17:52Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 2/2 I also excpect that Er-Kim will cover the same [--] countries as in previous agreements with Sentynl. Followed by 2-5 more agreements for e.g. Southern & Northern Europe UK Canada & Asia. https://www.globenewswire.com/news-release/2025/09/24/3155462/0/en/Er-Kim-Enters-Commercialization-Agreement-with-Sentynl-Therapeutics-for-Nulibry-fosdenopterin-and-Zokinvy-lonafarnib-Targeting-Ultra-Rare-Diseases.html Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 1/2 Quote from Zydus' latest earnings call November [--] [----] (link). I"  
[X Link](https://x.com/anyuser/status/2020851723292618982)  2026-02-09T13:26Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP I love seeing the fast and solid work behind the official ZYCUBO website (link). The video the available downloadable document and much more are top notch. https://zycubo.com/ https://zycubo.com/"  
[X Link](https://x.com/anyuser/status/2020931923519078490)  2026-02-09T18:44Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP New Substack post: Fortress Biotech - Anselamimab (CAEL-101) update after AstraZenecas Q4 [----] https://zellchair.substack.com/p/fortress-biotech-anselamimab-cael https://zellchair.substack.com/p/fortress-biotech-anselamimab-cael"  
[X Link](https://x.com/Zellchair/status/2021587807194460440)  2026-02-11T14:11Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Not a single update from Moderna regarding mRNA-1647 in the press release or presentation material for their Q4 [----] other than it being listed as still active in their pipeline (P. [--] of the presentation). Haven't listened to the earnings call yet"  
[X Link](https://x.com/anyuser/status/2022302094821122455)  2026-02-13T13:29Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP 4D-175 - Part [--] Although $FDMT have announced that due to financial reasons it will focus all its attention on 4D-150 in its pipeline they have now annonced that they do not want to wait with 4D-175 and is now seeking a "strategic partnership""  
[X Link](https://x.com/anyuser/status/2022405791903551671)  2026-02-13T20:21Z [--] followers, [--] engagements


"$FBIO $FBIOP 4D-175 Part [--] This is from 4D Molecular Therapeutics Investor Presentation in January (2026): https://ir.4dmoleculartherapeutics.com/static-files/1f6e166f-50a5-42a4-b159-69131cc49782 https://ir.4dmoleculartherapeutics.com/static-files/1f6e166f-50a5-42a4-b159-69131cc49782"  
[X Link](https://x.com/Zellchair/status/2022405995826421839)  2026-02-13T20:22Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP Triggers 2026-2027 https://zellchair.substack.com/p/fortress-biotech-triggers-20262027 https://zellchair.substack.com/p/fortress-biotech-triggers-20262027"  
[X Link](https://x.com/anyuser/status/2022663760796659720)  2026-02-14T13:26Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP All circles that can be closed within Gut seems to be closed within Crystalys now. Former Chairman President & CEO of Horizon Therapeutic which was acquired by Amgen (much because of KRYSTEXXA in Gut) now joins Crytalys. https://www.prnewswire.com/news-releases/crystalys-therapeutics-appoints-tim-walbert-former-horizon-therapeutics-ceo-as-independent-board-director-302684374.html https://www.prnewswire.com/news-releases/crystalys-therapeutics-appoints-tim-walbert-former-horizon-therapeutics-ceo-as-independent-board-director-302684374.html"  
[X Link](https://x.com/anyuser/status/2021602249223323961)  2026-02-11T15:08Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP 4D-175 - Part [--] Although $FDMT have announced that due to financial reasons it will focus all its attention on 4D-150 in its pipeline they have now annonced that they do not want to wait with 4D-175 and is now seeking a "strategic partnership""  
[X Link](https://x.com/anyuser/status/2022405791903551671)  2026-02-13T20:21Z [--] followers, [--] engagements


"$FBIO $FBIOP 4D-175 Part [--] 4D Molecular Therapeutics acquired Aevitas (a former Fortress subsidiary) short-form human factor H (AAV.sFH) asset for up to $140 million in potential milestones and additional royalties on net sales for Fortress"  
[X Link](https://x.com/anyuser/status/2022406263301435620)  2026-02-13T20:23Z [--] followers, [--] engagements


"$FBIO $FBIOP 4D-175 Part [--] A sale of 4D-175 in its entirety would mean immediate cash and/or increased opportunities for milestones and royalties in the future for Fortress"  
[X Link](https://x.com/anyuser/status/2022406569447850288)  2026-02-13T20:24Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP Crystalys Therapeutics CEO talks about the IPO window. https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2026-hold-for-biopharma-part-1-capital-allocation-and-dealmaking-U3B4EUN3GZGNXM6QI3ZGXVMNZY/ https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2026-hold-for-biopharma-part-1-capital-allocation-and-dealmaking-U3B4EUN3GZGNXM6QI3ZGXVMNZY/"  
[X Link](https://x.com/anyuser/status/2022381171972124782)  2026-02-13T18:43Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP UNLOXCYT Listen to the experts. Never heard so many "exciting" in such a short time. The fact that the study was done in the majority in the EU and Australia bodes well for the decisions on approval in these markets. https://thedermdigest.com/heres-why-dermatologists-are-excited-about-cosibelimab-ipdl-for-cscc-with-dr-emily-s-ruiz/ https://thedermdigest.com/heres-why-dermatologists-are-excited-about-cosibelimab-ipdl-for-cscc-with-dr-emily-s-ruiz/"  
[X Link](https://x.com/anyuser/status/2022375334050443649)  2026-02-13T18:20Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP Not a single update from Moderna regarding mRNA-1647 in the press release or presentation material for their Q4 [----] other than it being listed as still active in their pipeline (P. [--] of the presentation). Haven't listened to the earnings call yet"  
[X Link](https://x.com/anyuser/status/2022302094821122455)  2026-02-13T13:29Z [--] followers, [--] engagements


"Sources: https://irp.cdn-website.com/89dd0539/files/uploaded/Moderna.4Q25.final.pdf https://feeds.issuerdirect.com/news-release.htmlnewsid=4757591928778639&symbol=MRNA https://irp.cdn-website.com/89dd0539/files/uploaded/Moderna.4Q25.final.pdf https://feeds.issuerdirect.com/news-release.htmlnewsid=4757591928778639&symbol=MRNA"  
[X Link](https://x.com/anyuser/status/2022302177667006525)  2026-02-13T13:29Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP Fortress Biotech Helocyte Before Triplex CMV-HIV Co-Infection on ART (Phase 2) Readout https://zellchair.substack.com/p/fortress-biotech-helocyte-before https://zellchair.substack.com/p/fortress-biotech-helocyte-before"  
[X Link](https://x.com/anyuser/status/2022292198612422740)  2026-02-13T12:50Z [--] followers, [--] engagements


"Fortress Biotech $FBIO $FBIOP New Substack post: Fortress Biotech - Anselamimab (CAEL-101) update after AstraZenecas Q4 [----] https://zellchair.substack.com/p/fortress-biotech-anselamimab-cael https://zellchair.substack.com/p/fortress-biotech-anselamimab-cael"  
[X Link](https://x.com/Zellchair/status/2021587807194460440)  2026-02-11T14:11Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 2/2 I interpreted it as: [--]. Sentynl will have a strong coming year largely due to ZYCUBO [--]. ZYCUBO will be a driving part of the US business (first answer option from the respondent) in the coming years Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen to the Q&A around 30:45 and 39:45. https://t.co/Lv6Fvhd5H4 Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen"  
[X Link](https://x.com/anyuser/status/2021236280768479584)  2026-02-10T14:54Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Zydus Lifesciences Q ZYCUBO update Part 1/2 Quarter earnings yesterday and earnings call today. Listen to the Q&A around 30:45 and 39:45. https://zyduslife.com/public/pdf/EditedAudio.mp3 https://zyduslife.com/public/pdf/EditedAudio.mp3"  
[X Link](https://x.com/anyuser/status/2021235936281981390)  2026-02-10T14:52Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP I love seeing the fast and solid work behind the official ZYCUBO website (link). The video the available downloadable document and much more are top notch. https://zycubo.com/ https://zycubo.com/"  
[X Link](https://x.com/anyuser/status/2020931923519078490)  2026-02-09T18:44Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 2/2 I also excpect that Er-Kim will cover the same [--] countries as in previous agreements with Sentynl. Followed by 2-5 more agreements for e.g. Southern & Northern Europe UK Canada & Asia. https://www.globenewswire.com/news-release/2025/09/24/3155462/0/en/Er-Kim-Enters-Commercialization-Agreement-with-Sentynl-Therapeutics-for-Nulibry-fosdenopterin-and-Zokinvy-lonafarnib-Targeting-Ultra-Rare-Diseases.html Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 1/2 Quote from Zydus' latest earnings call November [--] [----] (link). I"  
[X Link](https://x.com/anyuser/status/2020851723292618982)  2026-02-09T13:26Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP ZYCUBO commercialization Part 1/2 Quote from Zydus' latest earnings call November [--] [----] (link). I expect Zydus/Sentynl to cover large markets where they have good sales capabilities in India USA Mexico and Brazil. https://zyduslife.com/investor/admin/uploads/16/0/Earnings-call-transcript-06-Nov-25.pdf https://zyduslife.com/investor/admin/uploads/16/0/Earnings-call-transcript-06-Nov-25.pdf"  
[X Link](https://x.com/anyuser/status/2020851531524833480)  2026-02-09T13:25Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Now the transcript has been released from Sun Pharma's latest quarter report last week. Recommended reading with several interesting details about UNLOXCYT launch. https://sunpharma.com/wp-content/uploads/2026/01/Press-Release-Sun-Pharma-Q3FY26-financial-result-on-January-31-2026.pdf https://sunpharma.com/wp-content/uploads/2026/01/Press-Release-Sun-Pharma-Q3FY26-financial-result-on-January-31-2026.pdf"  
[X Link](https://x.com/Zellchair/status/2020504784919527830)  2026-02-08T14:27Z [--] followers, [---] engagements


"Fortress Biotech $FBIO $FBIOP Menkes ZYCUBO - China With the advancement of the marketing application it is expected that Zycubo will be officially approved in China in 2027-2028 filling the gap in the specific treatment of Menkes disease in China" http://www.kaicheong.hk/a/xinwenzhongxin/2026020711946.html http://www.kaicheong.hk/a/xinwenzhongxin/2026020711946.html"  
[X Link](https://x.com/anyuser/status/2020193852842295702)  2026-02-07T17:52Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing